Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets

Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimer’s disease (AD). Emerging generative artificial intelligence (GAI) technologies...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei-Qi, Yan, Chao, Grabowska, Monika, Dickson, Alyson, Li, Bingshan, Wen, Zhexing, Roden, Dan, Stein, C., Embí, Peter, Peterson, Josh, Feng, QiPing, Malin, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371084/
https://www.ncbi.nlm.nih.gov/pubmed/37503019
http://dx.doi.org/10.21203/rs.3.rs-3125859/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371084/
https://www.ncbi.nlm.nih.gov/pubmed/37503019
http://dx.doi.org/10.21203/rs.3.rs-3125859/v1

Ejemplares similares